Physician profile
Jefferson H Lee
NPI 1295879633
$12,838.97
in general payments reported to CMS, 2019-2025
9 companies · $325 in 2025
The $325 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $424 · 2021: $75.17 · 2022: $398 · 2023: $10K · 2024: $1,294 · 2025: $325.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,750 · Travel and Lodging: $3,688 · Food and Beverage: $1,503.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,750.00 |
| Travel and Lodging | $3,688.33 |
| Food and Beverage | $1,503.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $10,288.74 | 2021-2025 | Carto 3, Qdot Micro Catheter |
| Abbott Laboratories | $1,137.28 | 2019-2025 | Aveir, Ensite |
| Boston Scientific Corporation | $803.93 | 2019-2025 | Watchman, General - Therapies, Farapulse |
| Medtronic, INC. | $306.80 | 2024-2025 | Selectsecure, Selectsite |
| Amgen INC. | $126.14 | 2024 | Repatha |
| Impulse Dynamics (USA) INC. | $126.05 | 2024 | Optimizer |
| Stryker Corporation | $18.27 | 2021 | |
| Medtronic Vascular, INC. | $16.88 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $14.88 | 2024 | Eliquis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jefferson Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.